Skip to main content
HR 318 117th Congress House Health Blood and blood diseases Cardiovascular and respiratory health Congressional oversight Emergency medical services and trauma care Government studies and investigations Health information and medical records Health technology, devices, supplies Infectious and parasitic diseases Internet and video services Internet, web applications, social media Medical tests and diagnostic methods Medicare

Safe Testing at Residence Telehealth Act of 2021

Introduced: January 25, 2022 Introduced by: Schweikert, David Republican · Arizona See on congress.gov
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 14, 2021
Referred to the Subcommittee on Health.
Jan 13, 2021
Referred to the Subcommittee on Health.
Jan 13, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 13, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Safe Testing at Residence Telehealth Act of 2021

This bill provides for Medicare payment of certain at-home diagnostic tests and telehealth assessments that are provided in relation to COVID-19 (i.e., coronavirus disease 2019).

Specifically, during the public health emergency, the bill requires Medicare payment of diagnostic tests for respiratory conditions other than COVID-19 (e.g., influenza) that are used to finalize a COVID-19 diagnosis and of COVID-19 blood tests that are ordered via telehealth, as well as for related telehealth assessments, regardless of whether the practitioner who orders the test is the one who furnishes it and regardless of the location of the practitioner.

The bill requires practitioners to report specified demographic data with respect to such tests and services in order to receive payment, and prohibits payment for in-person tests that were already ordered via telehealth.

What's happening now January 14, 2021

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 318: Safe Testing at Residence Telehealth Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-318/
MLA
"H.R. 318: Safe Testing at Residence Telehealth Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-318/.
Bluebook (legal)
H.R. 318, 117th Cong. (2026), https://openamerica.io/bill/117-HR-318/.
Markdown link
[H.R. 318: Safe Testing at Residence Telehealth Act of 2021](https://openamerica.io/bill/117-HR-318/)
Report a problem